Fresenius Medical Care

10/09/2026

At the 54th EDTNA/ERCA International Conference in Gdańsk, Poland, we’re putting the spotlight on the nurses at the heart of kidney care.

This year's theme, "Mind Matters in Nephrology: Caring Beyond the Kidneys," highlights the importance of integrated patient-centered care, a focus we're also bringing to our FME Corporate Education Session.

We invite you to join our session “Elevating Renal Care: From Technical Delivery to Integrative Care” on Sunday, September 27 in Hall 4.

Our team will showcase our Home and In-Center therapy solutions, with a focus on supporting nurses in delivering high-quality care across different settings and throughout the patient journey.

We're also proud to contribute 40 oral and poster presentations from our NephroCare nurses across 13 countries.

We’re looking forward to meaningful conversations with the nephrology nursing community.

📍 Gdańsk, Poland | 📅 September 26–29, 2026 | Booth 5

03/09/2026

Living with kidney disease changed Samroeng Getlim's life, but it didn't take away his independence 🙌

With overnight peritoneal dialysis on SILENCIA, he can rest comfortably at home at night and stay active during the day, allowing him to keep doing the things that matter most to him.

Samroeng's story is a reminder that every kidney care journey is unique. The right therapy can support not only treatment needs, but also the people, routines and moments that make life meaningful.

📹Watch Samroeng share how home dialysis became part of his everyday life and helped him move forward with confidence: https://www.youtube.com/watch?v=it8QjrmpDmk&t=1s

After being diagnosed with End-Stage Kidney Disease, this inspiring...

03/09/2026

We’re people caring for people.

Behind every dialysis treatment is an interdisciplinary team of people working together to care for the whole person.

At Fresenius Medical Care, our clinical teams support patients through some of the most important moments in their kidney care journeys. From building trust and offering encouragement to helping patients feel comfortable and supported, our work makes a meaningful impact, every day.

Hear from our patients and employees, and get an inside look at one of our dialysis centers.

And, if you are looking for a meaningful career where you can make a real impact in people’s lives, explore opportunities with Fresenius Medical Care: https://jobs.freseniusmedicalcare.com/

27/08/2026

📢 New Study Associates Hemodiafiltration (HDF) with a 28% Lower Relative Risk of all-cause mortality

A newly-published multinational real-world evidence study involving nearly 20,000 patients used a target trial emulation approach and found that hemodiafiltration (HDF) was associated with a 28% lower relative risk of all-cause mortality compared with those receiving high-flux hemodialysis. Published in the Journal of the American Society of Nephrology, the findings add to the substantial and growing body of evidence supporting HDF for people living with kidney failure.

As Fresenius Medical Care continues its nationwide rollout of HDF/HVHDF across the United States, we're expanding access to this advanced therapy and helping more patients benefit from the latest innovations in kidney care. Through research, innovation, and clinical excellence, we're working to improve outcomes for people living with kidney disease.

Learn more about the study and what it means for the future of kidney care: https://freseniusmedicalcare.com/en/media/newsroom/multinational-real-world-evidence-study-associating-high-volume-hemodiafiltration-with-lower-mortality-risk-than-conventional-hemodialysis/

Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis

25/08/2026

What if AI could help make kidney-friendly meal planning more personal? For people living with chronic kidney disease (CKD), planning meals can mean navigating complex nutritional requirements while also considering personal preferences, cultural tastes, and favorite cuisines.

In the latest Research in Brief, Sheng-Han Yueh, Data Scientist at The Renal Research Institute (RRI), shares how researchers developed an AI-assisted system to support dietitians in creating more personalized meal plans.

Drawing from a database of more than 300 kidney-friendly recipes, the system helps curate meals based on both clinical needs and individual preferences. Combined with dietitian oversight, this two-step approach aims to make meal planning more flexible, practical, and easier to follow.

Watch the full video on our website to learn more about how AI could support a more personalized approach to nutrition in kidney care: https://freseniusmedicalcare.com/en/media/multimedia/videos/research-in-brief-personalizing-meal-planning-for-people-with-ckd/?utm_source=facebook&utm_medium=organic_social&utm_campaign=25aug2026_rib_personalizing_meal_planning_ckd

19/08/2026

Meet Brittany, a Registered Dietitian at Fresenius Medical Care. For Brittany, supporting patients means more than reviewing lab results. It is about building trust, understanding each person’s unique needs, and helping them make choices that support their health every day.

In dialysis care, Registered Dietitians have the opportunity to form meaningful relationships with patients, provide personalized education, and be part of an interdisciplinary care team that helps people live fuller, healthier lives.

If you are a Registered Dietitian who is passionate about connecting with patients, supporting care journeys, and making an impact through nutrition, a career at Fresenius Medical Care is a great next step.

Explore meaningful career opportunities and learn more: https://jobs.freseniusmedicalcare.com/jobs?filter%5Bcountry%5D%5B0%5D=United%20States%20of%20America&filter%5Bcf_job_family%5D%5B0%5D=Food%20And%20Nutrition&page_number=1

07/08/2026

For more than a decade, Miguel Ángel Silva from Spain has built a life around dialysis, one that still includes summer days by the sea, time with family, creativity, and hope. With the support of his care team, he has learned to adapt, making treatment part of his life rather than letting it define it.

Miguel says, "Dialysis is a heavy burden in everyday life, but it keeps me going. If it weren’t for dialysis, I wouldn’t be here today."

A diagnosis of chronic kidney disease can bring uncertainty and many questions about what life will look like. But as shown by Miguel, it doesn't mean life has to stop.

👉 Read more about his journey and discover how resilience, compassionate care, and the simple moments in life makes it all worth it: https://freseniusmedicalcare.com/en/media/multimedia/videos/building-a-life-around-care-miguels-journey-on-dialysis/?utm_source=facebook&utm_medium=organic_social&utm_campaign=07august2926_cdi_patientstory_miguel

03/08/2026

News 📢: Today, Fresenius Medical Care published its Q2 2026 financial results, delivering solid organic revenue growth of 5% and accelerating operating income growth excluding special items to 23% at constant currency. Read the full financial results via the press release linked below.

Our CEO Helen Giza, said: “Fresenius Medical Care delivered another quarter of highly profitable growth, driven by solid organic revenue growth and improved profitability. Care Delivery achieved strong operating income growth. Importantly, underlying operating income improved by 34% excluding the positive TDAPA effects, driven by rate improvements and benefits from revenue cycle management. The U.S. rollout of our innovative 5008X CAREsystem is progressing at speed, now available in 227 U.S. clinics, having performed more than 600,000 treatments. We are excited by the benefits we are seeing through early insights from our scientific research initiative BEACON-US and the potential for this therapy to significantly improve patient outcomes in the U.S.”

Giza continued, “Operating income growth in the first half was in line with our planned phasing for the full year and we confirm our outlook for 2026. Through disciplined ex*****on of the FME Reignite strategy, we are further improving the quality of patient care, investing in innovation and profitable future growth, addressing regulatory headwinds – creating long-term value for our shareholders.”

Read more in today’s press release: https://freseniusmedicalcare.com/en/media/newsroom/q2-2026/?utm_source=facebook&utm_medium=organic_social&utm_campaign=03_august2026_q2_financieal_earnings&utm_content=corporate

03/08/2026

News 📢: The Supervisory Board of Fresenius Medical Care has appointed Cassie McLean as a member of the Management Board and Chief Executive Officer of the operating segment Care Delivery.

Michael Sen, Chairman of the Supervisory Board, commented: "Cassie McLean brings deep dialysis expertise, strong leadership, and a clear understanding of the performance drivers across the clinic business. I would like to thank Craig Cordola for his contributions and commitment to patients and wish him all the best in the future."

Read the press release: https://freseniusmedicalcare.com/en/media/newsroom/fresenius-medical-care-appoints-cassie-mclean-as-new-management-board-member-for-care-delivery/?utm_source=facebook&utm_medium=organic_social&utm_campaign=03_august2026_caredelivery_announcement&utm_content=corporate

29/07/2026

"I got my life back with HDF”

▶️ Hear Ronald's story and learn how HighVolumeHDF helped him feel like himself again.

Ronald shares his experience of living with kidney failure, the transition from conventional dialysis to Hemodiafiltration (HDF), and the profound impact HighVolumeHDF has had on his life. He talks about having more energy to spend time with family, pursue hobbies, and stay engaged in the activities he loves.

🌐 Visit our website for more patient resources about HighVolumeHDF via the link: www.myHDFjourney.com



The statements in this content reflect the personal experiences of the interviewees, and the described effects of the therapy may vary between individuals.
Patients should review the following information carefully and discuss it with their doctors to decide whether Hemodiafiltration is right for them.